Induction of eotaxin production by interleukin-4, interleukin-13 and lipopolysaccharide by nasal fibroblasts

Clinical and Experimental Allergy

Volumn 34, Issue 5, 2004, Pages 804-811

  Nonaka, M ^a   Pawankar, R ^a   Fukumoto, A ^a   Ogihara, N ^a   Sakanushi, A ^a   Yagi, T ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Eotaxin; Fibroblast; IL 4; LPS; Synergy

Indexed keywords

EOTAXIN; INTERLEUKIN 13; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BIOPSY; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; HUMAN; HUMAN CELL; LUNG FIBROBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN FIBROBLAST; SUPERNATANT;

CELL LINE; CHEMOKINES, CC; DOSE-RESPONSE RELATIONSHIP, DRUG; EOSINOPHILIA; FIBROBLASTS; HUMANS; INTERLEUKIN-13; INTERLEUKIN-4; LIPOPOLYSACCHARIDES; LUNG; NASAL MUCOSA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKIN; STATISTICS, NONPARAMETRIC; STIMULATION, CHEMICAL; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 2942609475     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2004.1954.x     Document Type: Article

References (42)

1. Jose PJ, Griffiths-Johnson DA, Collins PD et al. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J Exp Med 1994; 179:881-7.
2. Rothenberg ME, Ownbey R, Mehlhop PD et al. Eotaxin triggers eosinophil-selective chemotaxis and calcium flux via a distinct receptor and induces pulmonary eosinophilia in the presence of interleukin 5 in mice. Mol Med 1996; 2:334-48.
3. Ponath PD, Qin S, Ringler DJ et al. Cloning of human eosinophil chemoattractant, eotaxin. J Clin Invest 1996; 97:604-12.
4. Griffins-Johnson DA, Collins PD, Rossi AG, Jose PJ, Williams TJ. The chemokine, eotaxin, activates guinea-pig eosinophils in vitro and causes their accumulation into the lung in vivo. Biochem Biophys Res Commun 1993; 197:1167-72.
5. Yawalkar N, Uguccioni M, Scharer J et al. Enhanced expression of eotaxin and CCR3 in atopic dermatitis. J Invest Dermatol 1999; 113:43-8.
6. Lamkhioued B, Renzi PM, Abi-Younes S et al. Increased expression of eotaxin in bronchioalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation. J Immunol 1997; 159:4593-4601.
7. Cauna N, Hinderer KH, manzetti GW, Swanson EW. Fine structure of nasal polyps. Ann Otol Rhinol Laryngol 1972; 81:41-58.
8. Leung DY. Atopic dermatitis: the skin as a window into the pathogenesis of chronic allergic diseases. J Allergy Clin Immonol 1995; 96:302-18.
9. Roche WR, Williams JH, Beasley R, Holgate ST. Subepithelial fibrosis in the bronchi of asthmatics. Lancet 1989; 1:520-24.
10. Bachert C, Gevaert P, Holtappels G, Cuvelier C, van Cauwenberge P. Nasal polyposis: from cytokines to growth. Am J Rhinol 2000; 14:279-90.
11. Mochizuki M, Bartels J, Mallet AI, Christophers E, Schroder JM. IL-4 induces eotaxin: a possible mechanism of selective eosinophil recruitment in helmith infection and atopy. J Immunol 1998; 160:60-8.
12. Nonaka M, Nonaka R, Wooley K et al. Distinct immunohistochemical localization of IL-4 in human inflamed airway tissues. J Immonol 1995; 155:3234-44.
13. van der Heijden FL, Wierenga EA, Bos JD, Kapsenberg ML. High frequency of IL-4-producing CD4+ allergen-specific T lymphocytes in atopic dermatitis lesional skin. J Invest Dermatol 1991; 97:389-94.
14. Terada N, Hamano N, Nomura T et al. Interleukin-13 and tumor necrosis factor-α synergistically induce eotaxin production in human nasal fibroblast. Clin Exp Allergy 2000; 30:348-55.
15. Doucet C, Brouty-Boye D, Pottin-Clemenceau C, Canonica GW, Jasmin C, Azzarone B. Interleukin (IL) 4 and IL-13 act on human lung fibroblasts. J Clin Invest 1998; 101:2129-39.
16. Peden DB, Tucker K, Murphy P et al. Eosinophils influx to the nasal airway after local, low-level LPS challenge in humans. J Allergy Clin Immunol 1999; 104:388-94.
17. Michel O, Kips J, Duchateau J et al. Severity of asthma is related to endotoxin in house dust. Am J Respir Crit Care Med 1996; 154:1641-6.
18. Alfaro C, Sharma OP, Navarro L, Glovsky MM. Inverse correlation of expiratory lung flows and sputum eosinophils in status asthmatics. Ann Allergy 1989; 63:251-4.
19. Stoop AE, van der Heijden HA, Biewenga J, van der Baan S. Eosinophils in nasal polyps and nasal mucosa: an immunohistochemical study. J Allergy Clin Immunol 1993; 91:616-22.
20. Wahl SM, McCartney-Francis N, Mergenhagen SE. Inflammatory and immunomodulatory roles of TGF-β. Immunol Today 1989; 10:258-61.
21. Jordana M, Schulman J, Mcsharry C et al. Heterogeneous proliferative characteristics of human adult lung fibroblast lines and clonally derived fibroblasts from control and fibrotic tissue. Am Rev Respir Dis 1988; 137:579-84.
22. Chomczynsk P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162:156-9.
23. Pawankar R, Okuda M, Hasegawa S et al. Interleukin-13 gene expression in the nasal mucosa of perennial allergic rhinitics. Am J Respir Crit Care Med 1995; 152:2059-67.
24. Leung DY, Harbeck R, Bina P et al. Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis: evidence for a new group of allergens. J Clin Invest 1993; 92:1374-80.
25. Davey EJ, Thyberg J, Conrad DH, Severinson E. Regulation of cell morphology in B lymphocytes by IL-4: evidence for induced cytoskeletal changes. J Immunol 1998; 160:5366-73.
26. Blease K, Seybold J, Adcock IM, Hellewell PG, Burke-Gaffney A. Interleukin-4 and lipopolysaccharide synergize to induce vascular cell adhesion molecule-1 expression in human lung microvascular endothelial cells. Am J Respir Cell Mol Biol 1998; 18:620-30.
27. Ohkawara Y, Yamaguchi K, Maruyama N et al. In situ expression of the cell adhesion molecules in bronchial tissues from asthmatics with airflow limitations: in vivo evidence of VCAM-1/VLA-4 interactions in selective eosinophil infiltrations. Am J Respir Cell Mol Biol 1995; 12:4-12.
28. Nakajima H, Sago H, Nishimura T, Yoshida S, Iwamoto I. Role of vascular cell adhesion molecule 1/lymphocyte function-associated antigen 1 interactions in antigen-induced eosinophil and T cell recruitment into the tissue. J Exp Med 1994; 179:1145-54.
29. McCarty JM, Yee EK, Deisher TA, Harlan JM, Kaushansky K. Interleukin-4 induces endothelial vascular cell adhesion molecule-1 (VCAM-1) by an NF-kb-independent mechanism. FEBS Lett 1995; 372:194-8.
30. McKenzie AN, Culpepper JA, de Waal Malefyt R et al. Interleukin 13: a T cell derived cytokine that regulates human monocyte and B cell function. Proc Natl Acad Sci U S A 1993; 90:3735-9.
31. De Malefyt RW, Figdor CG, Huijbens R, Mohan PS, Bennett B. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes: comparison with IL-4 and modulation by IFN-γ or IL-10. J Immunol 1993; 151:6370-81.
32. Fukuda K, Fujitsu Y, Kumagai N, Nishida T. Characterization of Interleukin-4 receptor complex in human corneal fibroblasts. Invest Ophyhalmol Vis Sci 2002; 43:183-8.
33. Schmitt-Graff A, Desmouliere A, Gabiani G. Heterogeneity of myofibroblasts phenotypic feature: An example of fibroblastic cell plasticity. Virchows Arch 1994; 425:3-24.
34. Xing Z, Jordana M, Braciak T, Ohtoshi T, Gauldie J. Lipopolysaccharide induces expression of granulocyte/macrophage colony-stimulating factor, interleukin-8, and interleukin-6 in human nasal, but not lung, fibroblasts: evidence for heterogeneity within the respiratory tract. Am J Respir Cell Mol Biol 1993; 9:255-63.
35. Nonaka M, Pawankar R, Saji F, Yagi T. Distinct expression of RANTES and GM-CSF by lipopolysaccharide in human nasal fibroblasts but not in other airway fibroblasts. Int Arch Allergy Immunol 1999; 119:314-21.
36. Khalil N, Greenberg AH. The role of TGF-β in pulmonary fibrosis. In: Bock GR, Marsh J, editors. Clinical Applications of TGF-β. Chichester: John Wiley & Sons Ltd. Ciba Foundation Symposium, Vol. 157: 1991; 194-211.
37. Kelley J. Transforming growth factor-β. In: Kelley J, editor. Cytokines of the lung. New York: Marcel Dekker, 1992; 101-37.
38. 1). J Clin Invest 1992; 89:1662-8.
39. Mitani T, Okazaki N, Okuno Y et al. Endotoxin in maxillary sinus effusion from patients with chronic sinusitis. Nihon Jibiinnkouka Kansenshou Kenkyuukai Kaishi (in Japanese) 1985; 3:98-101.
40. Ricci M. IL-4: a key cytokine in atopy. Clin Exp Allergy 1994; 24:801-12.
41. Bachert C, Gevaert P, Holtappels G, Johansson SGO, van Cauwenberge P. Total and specific IgE in nasal polyps is related to local eosinophilic inflammation. J Allergy Clin Immunol 2001; 107:607-14.
42. Pawankar R, Okuda M, Yssel H, Okumura K, Ra C. Nasal mast cells in perennial allergic rhinitics exhibit increased expression of the Fc epsilon RI, CD40L, IL-4, and IL-13, and can induce IgE synthesis in B cells. J C I 1997; 99:1492-9.